- 专利标题： Medicaments for the treatment or prevention of anemia
-
申请号： EP10181768.2申请日： 2002-12-06
-
公开(公告)号： EP2289531B1公开(公告)日： 2018-07-04
- 发明人: Klaus, Stephen J. , Lin, Al Y. , Neff, Thomas B. , Wang, Qingjian , Guenzler-Pukall, Volkmar , Arend, Michael P. , Flippin, Lee A.
- 申请人： Fibrogen, Inc.
- 申请人地址： 409 Illinois Street San Francisco, CA 94158 US
- 专利权人： Fibrogen, Inc.
- 当前专利权人： Fibrogen, Inc.
- 当前专利权人地址： 409 Illinois Street San Francisco, CA 94158 US
- 代理机构： Goodfellow, Hugh Robin
- 优先权： US337082P 20011206; US349659P 20020116; US359683P 20020225; US386488P 20020605
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; C12N15/09 ; C12Q1/56 ; C12Q1/34 ; A61K31/00 ; A61K31/47 ; A61K31/4738 ; A61K31/63 ; A61P7/06 ; A61K38/17 ; C07K14/47 ; C07K14/505 ; G01N33/74 ; A61K31/472 ; A61K31/4745 ; A61K31/17 ; A61K31/4375 ; A61K31/44 ; A61K31/4418 ; A61K31/496
摘要：
The present invention relates to methods of stabilizing the alpha subunit of hypoxia inducible factor (HIF). The invention further relates to methods of preventing, pretreating, or treating conditions associated with HIF, including ischemic and hypoxic conditions. Compounds for use in these methods are also provided.
公开/授权文献
- EP2289531A3 Medicaments for increasing endogenous erythropoietine (EPO) 公开/授权日：2013-03-13
信息查询
IPC分类:
